Autori: Holmes Frankie A
| Naslov | Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial (Article) |
| Autori | Holmes Frankie A ... Tomasevic Zorica I ... (broj koautora 27) |
| Info | EUROPEAN JOURNAL OF CANCER, (2023), vol. 184 br. , str. 48-59 |
| Projekat | Puma Biotechnology Inc |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
